Search results summary
From Health Canada
Search criteria
- Status: Select all
- Company: BIOSIMILAR COLLABORATIONS IRELAND LIMITED
Search results
| Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
|---|---|---|---|---|---|---|---|---|---|
| Marketed | 02522160 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | ABEVMY | Human | Yes | PRESCRIPTION | 1 | BEVACIZUMAB | 400 MG / 16 ML |
| Marketed | 02522160 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | ABEVMY | Human | Yes | SCHEDULE D | 1 | BEVACIZUMAB | 400 MG / 16 ML |
| Marketed | 02522179 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | ABEVMY | Human | Yes | SCHEDULE D | 1 | BEVACIZUMAB | 100 MG / 4 ML |
| Marketed | 02522179 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | ABEVMY | Human | Yes | PRESCRIPTION | 1 | BEVACIZUMAB | 100 MG / 4 ML |
| Approved | 02567253 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | BOSAYA | Human | Yes | PRESCRIPTION | 1 | DENOSUMAB | 60 MG / ML |
| Approved | 02567253 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | BOSAYA | Human | Yes | SCHEDULE D | 1 | DENOSUMAB | 60 MG / ML |
| Marketed | 02484153 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | FULPHILA | Human | Yes | PRESCRIPTION | 1 | PEGFILGRASTIM | 10 MG / ML |
| Marketed | 02484153 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | FULPHILA | Human | Yes | SCHEDULE D | 1 | PEGFILGRASTIM | 10 MG / ML |
| Marketed | 02502380 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | HULIO | Human | Yes | SCHEDULE D | 1 | ADALIMUMAB | 20 MG / 0.4 ML |
| Marketed | 02502380 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | HULIO | Human | Yes | PRESCRIPTION | 1 | ADALIMUMAB | 20 MG / 0.4 ML |
| Marketed | 02502399 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | HULIO | Human | Yes | PRESCRIPTION | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
| Marketed | 02502399 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | HULIO | Human | Yes | SCHEDULE D | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
| Marketed | 02502402 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | HULIO | Human | Yes | SCHEDULE D | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
| Marketed | 02502402 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | HULIO | Human | Yes | PRESCRIPTION | 1 | ADALIMUMAB | 40 MG / 0.8 ML |
| Marketed | 02474425 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | OGIVRI | Human | Yes | SCHEDULE D | 1 | TRASTUZUMAB | 150 MG / VIAL |
| Marketed | 02474425 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | OGIVRI | Human | Yes | PRESCRIPTION | 1 | TRASTUZUMAB | 150 MG / VIAL |
| Marketed | 02474433 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | OGIVRI | Human | Yes | SCHEDULE D | 2 | TRASTUZUMAB | 440 MG / VIAL |
| Marketed | 02474433 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | OGIVRI | Human | Yes | PRESCRIPTION | 2 | TRASTUZUMAB | 440 MG / VIAL |
| Approved | 02567261 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | VEVZUO | Human | Yes | PRESCRIPTION | 1 | DENOSUMAB | 120 MG / 1.7 ML |
| Approved | 02567261 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | VEVZUO | Human | Yes | SCHEDULE D | 1 | DENOSUMAB | 120 MG / 1.7 ML |
| Marketed | 02535858 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | YESAFILI | Human | Yes | PRESCRIPTION | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02535858 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | YESAFILI | Human | Yes | SCHEDULE D | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02558238 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | YESAFILI | Human | Yes | PRESCRIPTION | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02558238 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | YESAFILI | Human | Yes | SCHEDULE D | 1 | AFLIBERCEPT | 2 MG / 0.05 ML |
| Marketed | 02562081 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | YESINTEK | Human | Yes | SCHEDULE D | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
| Marketed | 02562081 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | YESINTEK | Human | Yes | PRESCRIPTION | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
| Marketed | 02562103 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | YESINTEK | Human | Yes | PRESCRIPTION | 1 | USTEKINUMAB | 90 MG / ML |
| Marketed | 02562103 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | YESINTEK | Human | Yes | SCHEDULE D | 1 | USTEKINUMAB | 90 MG / ML |
| Approved | 02566478 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | YESINTEK | Human | No | PRESCRIPTION | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
| Approved | 02566478 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | YESINTEK | Human | No | SCHEDULE D | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
| Marketed | 02562111 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | YESINTEK I.V. | Human | Yes | SCHEDULE D | 1 | USTEKINUMAB | 5 MG / ML |
| Marketed | 02562111 | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | YESINTEK I.V. | Human | Yes | PRESCRIPTION | 1 | USTEKINUMAB | 5 MG / ML |
Application information
Related information
Contact us
Version 4.0.4